P27 JUMC
From LipidomicsWiki
(Difference between revisions)
Line 1: | Line 1: | ||
{{Infobox_Institution | {{Infobox_Institution | ||
- | |||
|myInstitutionname=Jagiellonian University Medical College - Prof. Aldona Dembinska-Kieć MD PhD | |myInstitutionname=Jagiellonian University Medical College - Prof. Aldona Dembinska-Kieć MD PhD | ||
|myLogo= | |myLogo= | ||
Line 11: | Line 10: | ||
}}<br> <br> | }}<br> <br> | ||
- | + | ||
- | [[Category:Project_organisation]] | + | [[Category:Project_organisation]] |
Revision as of 08:25, 20 July 2011
Institution | Jagiellonian University Medical College - Prof. Aldona Dembinska-Kieć MD PhD | |
Principal investigator | {{{myPrincipal_investigator}}} | |
Country | Poland | |
Beneficiary Number | P09 | |
About us | ||
Contributions | The Dembinska-Kiec lab brings access to patients with diabetes, metabolic syndrome and HIV. They have unique access to adipose tissue from HIV patients treated with protease inhibitors which generates lipodystrophy. They also can provide genetic and lipidomic analysis of such tissue. | |
Member of Taskforces | Task Force II, Task Force IV, Task Force VI, and Task Force IX | |
Member of Workpackages | WP4 and WP8 |